Charles K N Chan

Summary

Affiliation: University of Toronto
Country: Canada

Publications

  1. ncbi request reprint The pulmonary effects of long-term exposure to aerosol pentamidine: a 5-year surveillance study in HIV-infected patients
    James Obaji
    Joint Division of Respirology, University Health Network and Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada
    Chest 123:1983-7. 2003
  2. ncbi request reprint Community acquired pneumonia (CAP): an update
    C K Chan
    Department of Medicine, University Health Network and Mount Sinai Hospital, University of Toronto, Canada
    J Chemother 13:23-7. 2001
  3. pmc A randomized controlled trial to assess the efficacy of tiotropium in Canadian patients with chronic obstructive pulmonary disease
    Charles K N Chan
    University Health Network, Toronto General Hospital, Toronto, Canada
    Can Respir J 14:465-72. 2007
  4. ncbi request reprint Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis
    Theodore K Marras
    Joint Division of Respirology, Department of Medicine, University Health Network, and Mount Sinai Hospital, University of Toronto, Toronto, Canada
    Am J Med 116:385-93. 2004
  5. pmc Pneumonia severity index in the immunocompromised
    K M Sanders
    Department of Medicine, University of Toronto, Toronto, Canada
    Can Respir J 13:89-93. 2006
  6. ncbi request reprint Tracheobronchial involvement as a sole manifestation of relapsing polychondritis
    Nimrod Maimon
    Division of Respirology, Department of Medicine, University Health Network Division of Rheumatology, Department of Medicine, Mount Sinai Hospital Departments of Medical Imaging Pathology Thoracic Surgery, University Health Network, University of Toronto, Toronto, Canada
    J Bronchology Interv Pulmonol 17:5-10. 2010
  7. ncbi request reprint The use of guidelines for the empirical treatment of hospital-acquired pneumonia
    M S Miletin
    Division of Respirology, Department of Medicine, The University Health Network and Mount Sinai Hospital, University of Toronto, Toronto, Ontario
    Can Respir J 8:255-60. 2001
  8. ncbi request reprint Everolimus in pulmonary transplantation: pharmacokinetics and exposure-response relationships
    John M Kovarik
    Novartis Pharmaceuticals, Basel, Switzerland
    J Heart Lung Transplant 25:440-6. 2006

Collaborators

Detail Information

Publications8

  1. ncbi request reprint The pulmonary effects of long-term exposure to aerosol pentamidine: a 5-year surveillance study in HIV-infected patients
    James Obaji
    Joint Division of Respirology, University Health Network and Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada
    Chest 123:1983-7. 2003
    ..To assess the effects of long-term exposure to aerosolized pentamidine (AP) for the prophylaxis of Pneumocystis carinii pneumonia on the pulmonary function...
  2. ncbi request reprint Community acquired pneumonia (CAP): an update
    C K Chan
    Department of Medicine, University Health Network and Mount Sinai Hospital, University of Toronto, Canada
    J Chemother 13:23-7. 2001
    ..Empiric treatment guidelines for CAP have been developed and their use has been shown to simplify treatment regimens and improve outcome...
  3. pmc A randomized controlled trial to assess the efficacy of tiotropium in Canadian patients with chronic obstructive pulmonary disease
    Charles K N Chan
    University Health Network, Toronto General Hospital, Toronto, Canada
    Can Respir J 14:465-72. 2007
    ..Patients with chronic obstructive pulmonary disease (COPD) who smoke have a greater annual rate of decline in forced expiratory volume in 1 s (FEV(1)) than those patients who have stopped smoking...
  4. ncbi request reprint Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis
    Theodore K Marras
    Joint Division of Respirology, Department of Medicine, University Health Network, and Mount Sinai Hospital, University of Toronto, Toronto, Canada
    Am J Med 116:385-93. 2004
    ..To assess the efficacy of oral antibiotics in patients hospitalized with community-acquired pneumonia and to identify factors precluding oral therapy...
  5. pmc Pneumonia severity index in the immunocompromised
    K M Sanders
    Department of Medicine, University of Toronto, Toronto, Canada
    Can Respir J 13:89-93. 2006
    ..The pneumonia severity index (PSI) accounts for many comorbidities, but not immunosuppression...
  6. ncbi request reprint Tracheobronchial involvement as a sole manifestation of relapsing polychondritis
    Nimrod Maimon
    Division of Respirology, Department of Medicine, University Health Network Division of Rheumatology, Department of Medicine, Mount Sinai Hospital Departments of Medical Imaging Pathology Thoracic Surgery, University Health Network, University of Toronto, Toronto, Canada
    J Bronchology Interv Pulmonol 17:5-10. 2010
    ..To report the clinical, imaging, and pathologic manifestations of case series of patients in whom the only systemic expression of relapsing polychondritis (RP) was their airway complications...
  7. ncbi request reprint The use of guidelines for the empirical treatment of hospital-acquired pneumonia
    M S Miletin
    Division of Respirology, Department of Medicine, The University Health Network and Mount Sinai Hospital, University of Toronto, Toronto, Ontario
    Can Respir J 8:255-60. 2001
    ..49). CONCLUSIONS: Institutional and ATS guidelines for the empirical treatment of HAP are less widely used than would be predicted by chance at The University Health Network. The clinical utility of these guidelines remains to be proven...
  8. ncbi request reprint Everolimus in pulmonary transplantation: pharmacokinetics and exposure-response relationships
    John M Kovarik
    Novartis Pharmaceuticals, Basel, Switzerland
    J Heart Lung Transplant 25:440-6. 2006
    ..In this study we evaluated exposure, safety and efficacy data from an international trial of everolimus. We sought to identify a tolerated and efficacious range for blood levels of this agent in maintenance lung transplant recipients...